Ashish Tripathi of Tzar Labs and Anish Tripathi of Epigeneres spoke to Bharatvaarta about their innovation and answered many questions posed specifically by medical professionals, which Bharatvaarta had crowd-sourced.
The two brothers are passionate about the social impact of an early cancer diagnosis and prognosis - this not just helps families control their medical expenses but also provides lifespan longevity to the impacted patients. The test is named HrC and there is a deeply personal story behind this, which was also covered by the Tripathi brothers.
Ashish has been an investment banker working across multiple countries while Anish is a supply chain expert and consultant, also with extensive global and India expertise. They plan to launch the test in India first, although this has a huge global impact.
Will an Indian innovation in healthcare leave a lasting impact on the way the world fights with cancer? Hear from the two individuals who may be at the cusp of making history.